Cargando…

An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018

Elevated blood pressure (BP) is a growing burden worldwide and is the leading cause of mortality and disability-adjusted life years all over the world. May Measurement Month (MMM) is a global initiative aimed to raise awareness of high BP and to act as a temporary solution to the lack of screening p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zelveian, Parounak, Avagyan, Avag, Minasyan, Arsen, Hayrumyan, Samvel, Gourgenyan, Svetlana, Hakobyan, Zoya, Kzhdryan, Hovhannes, Hakobjanyan, Vahan, Ustyan, Tsiala, Gharibyan, Heghine, Melkonyan, Arevik, Aroyan, Siranush, Vatinyan, Susanna, Beaney, Thomas, Ster, Anca Chis, Poulter, Neil R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455293/
https://www.ncbi.nlm.nih.gov/pubmed/32884458
http://dx.doi.org/10.1093/eurheartj/suaa017
Descripción
Sumario:Elevated blood pressure (BP) is a growing burden worldwide and is the leading cause of mortality and disability-adjusted life years all over the world. May Measurement Month (MMM) is a global initiative aimed to raise awareness of high BP and to act as a temporary solution to the lack of screening programmes worldwide. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May to July 2018. Blood pressure measurement, the definition of hypertension (HTN) and statistical analysis followed the standard MMM protocol. The study was conducted in public areas (17 sites in Yerevan and 22 in regions), both indoor and outdoor, as well as in 78 primary care centres. A total of 21 112 individuals were screened during MMM18, of which 20 732 had three BP measurements available. The mean age of screened individuals was 46.2 ± 17.3 years, 57.8% were female. At the time of screening, 26.1% were on antihypertensive medication. After imputation, the percentage of participants with HTN was 38.7%, and 76.7% of them were aware of their high BP. Of participants receiving treatment, 47.1% had a controlled BP. MMM18 was the largest BP screening campaign undertaken in Armenia. We found that the proportion of HTN is substantial in Armenia, which may be a vital contributor to the growing burden of non-communicable diseases. Our results also suggest that untreated HTN is common and when treated still not adequately controlled in Armenia. The current situation, with an insufficient control rate of HTN, must be changed as soon as possible.